InvestorsHub Logo
Followers 14
Posts 2928
Boards Moderated 0
Alias Born 09/27/2010

Re: daBoze post# 68822

Thursday, 06/13/2013 11:22:39 AM

Thursday, June 13, 2013 11:22:39 AM

Post# of 146240
daBoze,

This is an email from Dr. Seymour that I posted some time ago:


Subject: Re: FDA
From: drgeno@mac.com
Date: Wed, 29 May 2013 16:49:30 -0400
To: lorenzo_manaigo@hotmail.com

2 weeks for Phase I and 2 weeks for phase IIa

We should get breakthrough drug designation which could give approval next year

Eugene Seymour, MD MPH
Chief Executive Officer
NanoViricides, Inc
310-486-5677
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News